Standard Chartered reports $4 billlion profit

London-based Standard Chartered has reported a $4.04 billion profit, despite $300 million in US subprime debt-related writedowns.

The bank's 2007 annual report, released on February 26, also revealed that it had written down a total of $133 million due to investments held in Whistlejacket Capital, a structured investment vehicle sponsored by the group that went into receivership this month. Losses totalling $122 million were attributed to writedowns and impairment charges on asset-backed securities (ABSs).

Commenting on the results, Peter Sands, the group's chief executive, said: “We have faced challenges and taken some writedowns as a result of the financial turmoil.” The bank said it had had to make “difficult decisions”, particularly referencing Whistlejacket, for which it said it had not been able to find a viable solution, mainly due to “the pace of continuing deterioration in the market for certain asset classes".

On February 11, Whistlejacket advised that it had breached its capital note net asset value trigger of 50%, which was an enforcement event, requiring the security trustee, BNY Corporate Trustee Service, to appoint a receiver to manage it.

The bank also stated that it had no direct exposure and very limited indirect exposure to US subprime assets, with its entire exposure to ABSs, including collateralised debt obligations, being under $6 billion.

see also : Standard Chartered will fund troubled SIV
Standard Chartered takes $46 million profit hit

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here